RecruitingNCT06417437
Medication, brain stimulation, or neurofeedback approaches for depression and bipolarity
About this title
Read the official source — NCT06417437Medication studyAges 12+China
Understand this study
Who could participate?
Listed age limits: from 12 years.
- Listed locations
- ShanghaiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: July 1, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 400
- Sponsor
- Shanghai Mental Health Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Behavioral
- Intervention type
- Behavioural, Device, Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- China
- Age range
- Over 12 Years
- Official registry ID
- NCT06417437
- Official title
Show the full official title
New Non-invasive Brain-computer Interface: Theory, Technology and Application Demonstration - Studies on and Intervention for Depressed People Based on Non-invasive BCI and Application Verification
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Shanghai
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including SSRI.
Who can participate?
Listed age limits: from 12 years.
Is this study still recruiting?
The registry lists this study as recruiting.
